Skip to main content
Tech.euFundingExplorerBeta

Sophia Genetics

Helps clinicians and physicians PREdict better genetic diseases

Sophia Genetics has raised €212M across 5 funding rounds from 8 investors, most recently a Series D+ round in Oct 2020. Based in Saint-Sulpice, Switzerland; founded 2011; active in Software and Healthtech. Data as of 28 Oct 2026.

Saint-Sulpice, SwitzerlandFounded 2011sophiagenetics.com ↗
Total raised
€212M
€211,724,760
Funding rounds
5
Investors
8
distinct backers
Active since
2014-07
latest 2020-10

Funding by year

EUR raised per year
Sophia Genetics — funding by year — interactive chart.
Data table
Sophia Genetics — funding by year
2014€10M
2015€14M
2017€26M
2018€67M
2020€94M

Signals

High confidence
Raise-next likelihood11
base rate 53% for Series D+
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood13
base rate 11% (2+ rounds)
  • ▲ €100M+ raised
  • ▲ 5 rounds raised
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

5 rounds
DateStageAmountInvestors
2020-10-01Series D+€94MaMoon FundView deal →
2019-01-01Series D+€67MBalderton CapitalView deal →
2017-07-14Series D+€26M360 Capital Partners,Alychlo,Balderton Capital,Invoke Capital PartnersView deal →
2015-12-01Series C€14M—View deal →
2014-07-01Series B€10MEndeavour Vision,Invoke Capital Partners,Swisscom VenturesView deal →

Similar companies

same sector or country

Global coverage: FundingData